Bombay Institute of Pharmacy & Research (BIPR), Dombivli, established in 2023 under the aegis of the Shri Yashwantrao Bhonsale Education Society (SYBES), Sawantwadi, is a dynamic institution committed to excellence in pharmaceutical education, research, innovation and professional development. Building upon the Society's rich legacy of educational excellence since 2002, BIPR strives to nurture competent, ethical, socially responsible and globally competitive pharmacy professionals capable of addressing the evolving challenges of healthcare and the pharmaceutical industry.
Strategically located in Dombivli (East), Maharashtra, BIPR offers a vibrant academic ecosystem supported by state-of-the-art infrastructure, modern laboratories, digital learning resources and a highly qualified, experienced and dedicated faculty. The institute is approved by the Pharmacy Council of India (PCI) and the Directorate of Technical Education (DTE), Maharashtra, offering the Bachelor of Pharmacy (B. Pharm.) programme affiliated with the University of Mumbai and the Diploma in Pharmacy (D. Pharm.) programme affiliated with MSBTE, Mumbai.
In alignment with the transformative vision of the National Education Policy (NEP) 2020, BIPR embraces learner-centric, multidisciplinary and competency-based education that promotes flexibility, creativity, critical thinking and lifelong learning. The institute has adopted the principles of Outcome-Based Education (OBE), ensuring that every aspect of teaching, learning and assessment is aligned with clearly defined Programme Outcomes and Graduate Attributes. This outcome-oriented approach enables students to acquire not only sound pharmaceutical knowledge but also the professional competencies, problem-solving abilities, ethical values and communication skills essential for successful careers and lifelong professional growth.
Recognizing the transformative impact of the Fourth Industrial Revolution (Industry 4.0) on healthcare and pharmaceutical sciences, BIPR continuously integrates emerging technologies, digital tools and innovative pedagogical practices into its academic framework. The institute promotes experiential and technology-enabled learning through simulation-based education, research-driven projects, industrial exposure, interdisciplinary collaborations and innovation-led initiatives. Students are encouraged to develop competencies in data-driven decision-making, digital health, pharmaceutical innovation, entrepreneurship and sustainable healthcare practices, preparing them to thrive in an increasingly technology-driven global environment.
BIPR firmly believes that excellence in pharmaceutical education extends beyond classroom instruction. The institute offers a holistic educational experience by integrating academics with laboratory training, industrial visits, internships, guest lectures by eminent academicians and industry experts, workshops, seminars, value-added certification programmes and community engagement activities. This comprehensive approach bridges the gap between academia and industry while fostering research aptitude, innovation, leadership, teamwork and professional ethics.
The institute remains steadfast in its commitment to producing competent, practice-ready and socially responsible pharmacy graduates who meet the expectations of patients, employers, regulatory authorities, academia and the pharmaceutical industry. Through continuous quality improvement, industry-academia collaboration, research and innovation, entrepreneurship development and skill enhancement initiatives, BIPR ensures that its graduates possess the knowledge, technical expertise, professional attitude and adaptability required to excel in a rapidly evolving healthcare ecosystem.
Guided by the core values of academic excellence, innovation, integrity, inclusivity and continuous quality enhancement, Bombay Institute of Pharmacy & Research aspires to emerge as a nationally recognized centre of excellence in pharmaceutical education and research. The institute is dedicated to developing future-ready pharmacists, researchers, innovators and healthcare leaders who contribute meaningfully to advancing pharmaceutical sciences, improving patient care and serving society at both national and global levels.